| Primary information |
|---|
| sequence ID | Seq_9711 |
| Peptide sequence | YFVELGTQPAT |
| CancerPDF_ID | CancerPDF_ID757, CancerPDF_ID9434, |
| PMID | 19795908,24694173 |
| Protein Name | Apolipoprotein A-II,Apolipoprotein A-II |
| UniprotKB Entry Name | APOA2_HUMAN,APOA2_HUMAN |
| Fluid | Plasma,Ascites fluid |
| M/Z | 613.31,NA |
| Charge | 2,1 |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | LC-MS,LTQ-Orbitrap XL |
| Peptide Identification technique | MALDI-TOF/TOF,X tandem for peptide identification |
| Quantification Technique | LC-MRM (multiple reaction monitoring),NA |
| Labelled/Label Free | Labelled,Label Free |
| FDR | less than 7%,NA |
| CancerPDF_ID | CancerPDF_ID757, CancerPDF_ID9434, |
| p-Value | NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,"X tandem for peptide identification,Scaffold 2 software for any modification analysis" |
| Length | 11,11 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Ovarian cancer |
| Database | NCBI refseq Protein Database,IPI00021854 |
| Modification | NA,NA |
| Number of Patients | "36 normal, 23 patients",3 ovarian cancer patient and 3 non cancerous control |
| Regulation | NA,Uniquely expressed in ovarian cancer patient |
| Validation | NA,NA |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |